Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Precise capsule formulation ensures consistent dosing across experimental protocols, reducing variability that can impact research results
Keep a symptom journal to note improvements in energy, mood, sleep, or focus
Purchasing or supplying it outside of this framework is not legally sanctioned and carries significant risks, including exposure to counterfeit or contaminated products
US$ 24.68
US$ 28.86
US$ 26.88
US$ 22.73
US$ 27.73
US$ 20.23
